17. When managing NSGCTs, PM is indicated for select patients with limited number of lung
abnormalities after first-line or second-line platin-based chemotherapy suspected of …

Pulmonary metastasectomy is an established treatment that can provide improved long-term
survival for patients with metastatic tumor (s) in the lung. In this mini-review, we discuss the …

Metastasectomy is the only curative option for some patients with secondary pulmonary
malignancy. Many studies suggest a survival benefit in selected patients if complete …

Introduction The 5-year overall survival rate of patients undergoing complete surgical
resection of pulmonary metastases (PM) from colorectal cancer (CRC) and sarcoma remains …

Surgical resection is a widely accepted treatment for pulmonary metastases on the condition
that a complete resection can be obtained. However, many patients will develop recurrent …

Standard treatment options in patients with lung cancer and pulmonary metastases are
surgery, radiotherapy, chemotherapy, and immunotherapy. For reducing clinical …

To evaluate tumor response after treating unresectable lung metastases with
transpulmonary chemoembolization (TPCE) in palliative intention. From 2001 to 2005, 52 …

Objectives In vivo lung perfusion (IVLP) is an emergent strategy to treat lung metastases
because it allows localized delivery of chemotherapy with minimal systemic exposure …

Background Up to 66% of patients show local pulmonary disease progression after
pulmonary metastasectomy. Regional treatment with isolated lung perfusion (ILuP) may …

Objective: Surgical resection of lung metastases is a widely accepted procedure but 5-year
survival rates remain low and vary between 20% and 50%. Isolated lung perfusion (ILuP) is …